Promotion at EGEN
This article was originally published in Scrip
Executive Summary
EGEN, a US biopharmaceutical company specialising in nucleic acid therapeutics and delivery, has promoted Dr Jason Fewell from director of biology and pharmacology to vice-president of preclinical research and development.